2026, Number S1
<< Back Next >>
Rev Mex Anest 2026; 49 (S1)
Incorporating synthetic drug arsenal into the management of critical bleeding in children
Medina-Peña L
Language: Spanish
References: 7
Page: 397-399
PDF size: 814.43 Kb.
Text Extraction
No abstract.
REFERENCES
Martínez-Antón A. Hemorragia masiva en Pediatría. Protoc Diagn TerPediatr. 2021;1:345-354.
Tanaka KA, Bolliger D. Transfusion and coagulation therapy. En:Pharmacology and physiology for anesthesia. Elsevier; 2019. p. 849-869.
Arnold P. Medications for hemostasis. En: Coté CJ, Lerman J, AndersonBJ. A practice of anesthesia for infants and children (Sixth ed). Elsevier;2019. p. 482-499.
Alsabri M, Aziz MM, Fahmy K, Zayed A, Elkefl MT, Ebraheem EA,et al. Tranexamic acid in pediatric care: a comprehensive overview.J Pediatr Pharmacol Ther. 2026;31:18-29. doi: 10.5863/JPPT-25-00027.
Gobbie S, Faraoni D. Tranexamic acid and perioperative bleedingin children: what do we still need to know? Curr Opin Anesthesiol.2019;32:343-352. doi: 10.1097/ACO.0000000000000728.
Barrett L, Curry N. Transfusion in trauma: empiric or guidedtherapy? Res Pract Thromb Haemost. 2024;9:102663. doi: 10.1016/j.rpth.2024.102663.
Pérez-Ferrer A, García-Erce JA, Muñoz M. El paciente pediátrico. En:Medicina Transfusional. Patient Blood Management (segunda edición).Editorial Médica Panamericana; 2019. p. 161-172.
Full text